000 01525 a2200361 4500
005 20250513095442.0
264 0 _c19961220
008 199612s 0 0 eng d
022 _a0021-972X
024 7 _a10.1210/jcem.81.3.8772548
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnderson, R A
245 0 0 _aComparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cMar 1996
300 _a902-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAndrostane-3,17-diol
_xanalogs & derivatives
650 0 4 _aCholestenone 5 alpha-Reductase
650 0 4 _aContraceptive Agents, Male
_xpharmacology
650 0 4 _aDihydrotestosterone
_xblood
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHormones
_xurine
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOligospermia
_xchemically induced
650 0 4 _aOxidoreductases
_xmetabolism
650 0 4 _aTestosterone
_xanalogs & derivatives
700 1 _aWallace, A M
700 1 _aWu, F C
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 81
_gno. 3
_gp. 902-8
856 4 0 _uhttps://doi.org/10.1210/jcem.81.3.8772548
_zAvailable from publisher's website
999 _c8769322
_d8769322